Comparison of complications after D2 and D3 dissection for gastric cancer

被引:0
|
作者
Bostanci, EB [1 ]
Yol, S [1 ]
Kayaalp, C [1 ]
Ozogul, Y [1 ]
Aydin, C [1 ]
Atalay, F [1 ]
Akoglu, M [1 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Dept Gastrointestinal Surg, Ankara, Turkey
来源
EJSO | 2004年 / 30卷 / 01期
关键词
gastric cancer; gastrectomy; lymph node dissection; mortality; morbidity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. D3 dissection is accepted as having higher rates of mortality and morbidity than D2 dissection. In this study, we aimed to evaluate the mortality and morbidity rates of D3 dissection in our department and to compare these with mortality and morbidity after D2 dissection. Patients and methods. All patients who underwent radical gastric resection with lymph node dissection for gastric adenocarcinoma between June 1999 and June 2002 were evaluated. Clinicopathologic features of the tumour, the resection and lymphadenectomy, the postoperative mortality and morbidity were analysed. Results. There were 359 patients admitted for the treatment of gastric cancer. One hundred twenty four underwent palliative resection and 134 underwent resection with curative intent. Of 34/134 patients, underwent gastric resection with D3 dissection, and 100 underwent D2 dissection. The overall operative mortality rate of D2 and D3 dissections was 1 and 8.8%, respectively (p < 0.05). The relaparotomy rate was almost doubled in D3 dissection group (11.8% vs. 6%) but this difference was not statistically significant. D3 dissection was also associated with an increase in morbidity (35.3% vs. 10%, p < 0.05). Conclusions. This study indicates that D3 dissection can be performed with reasonable safety. It may be a useful alternative procedure in advanced cases for which additional risks of surgical morbidity and mortality are felt to be outweighed by potential benefits to patients. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [21] Gallstone disease after extended (D2) lymph node dissection for gastric cancer
    Akatsu, T
    Yoshida, M
    Kubota, T
    Shimazu, M
    Ueda, M
    Otani, Y
    Wakabayashi, G
    Aiura, K
    Tanabe, M
    Furukawa, T
    Saikawa, Y
    Kawachi, S
    Akatsu, Y
    Kumai, K
    Kitajima, M
    WORLD JOURNAL OF SURGERY, 2005, 29 (02) : 182 - 186
  • [22] TREATMENT OUTCOME AFTER D2 DISSECTION IN OPERABLE GASTRIC CANCER - A RETROSPECTIVE ANALYSIS
    Shaikat, Gupta
    Sudipto, Maitra
    Chanchal, Goswami
    Mahesh, Goenka
    Deepak, Ray
    Subrata, Saha
    ANNALS OF ONCOLOGY, 2014, 25 : 59 - 59
  • [23] In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection—D1 Versus D2 Versus D3?
    Harveshp Mogal
    Ryan Fields
    Shishir K. Maithel
    Konstantinos Votanopoulos
    Annals of Surgical Oncology, 2019, 26 : 2912 - 2932
  • [24] In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3?
    Mogal, Harveshp
    Fields, Ryan
    Maithel, Shishir K.
    Votanopoulos, Konstantinos
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2912 - 2932
  • [25] Combinations of vitamins A, D2 and D3 have synergistic effects in gastric and colon cancer cells
    Mahady, Gail B.
    Lawal, Temitope O.
    Patel, Shitalben
    Raut, Nishikant
    Wicks, Sheila M.
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2019, 9 (12): : 749 - 771
  • [26] A Prospective Observational Study of 468 Patients Undergoing D2 or D3 Lymphadenectomy for Gastric Cancer
    Bostanci, Erdal Birol
    Ozer, Ilter
    Ercan, Metin
    Ulas, Murat
    Koc, Umit
    Karaman, Kerem
    Dalgic, Tahsin
    Ozogul, Yusuf
    Akoglu, Musa
    HEPATO-GASTROENTEROLOGY, 2013, 60 (123) : 624 - 627
  • [27] SEPARATION OF VITAMINS D2 AND D3 AS ISOTACHYSTEROLS D2 AND D3 BY GAS-LIQUID CHROMATOGRAPHY
    SHEPPARD, AJ
    LACROIX, DE
    PROSSER, AR
    JOURNAL OF THE ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS, 1968, 51 (04): : 834 - &
  • [28] D1 AND D2 AND D3
    HEALY, D
    BRITISH JOURNAL OF PSYCHIATRY, 1991, 159 : 319 - 324
  • [29] Vitamin D2 or vitamin D3?
    Mistretta, V. I.
    Delanaye, P.
    Chapelle, J. -P.
    Souberbielle, J. -C.
    Cavalier, E.
    REVUE DE MEDECINE INTERNE, 2008, 29 (10): : 815 - 820
  • [30] D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications
    Vural, Veli
    Saylam, Baris
    Comcali, Bulent
    Duzgun, Arife Polat
    Ozer, Mehmet Vasfi
    Coskun, Faruk
    TURKISH JOURNAL OF SURGERY, 2013, 29 (01) : 1 - 6